Regarding the entire cohort of HER2-positive/TN breast cancer patients, the ROC curve for baseline SUVmax and baseline SUVmean showed an AUC of 0.82 and 0.83, respectively (Additional file 1: Table S3). This evidence concerns the gene ERBB2 and breast carcinoma.